tert-Butyl 3-bromo-4-formyl-1H-indole-1-carboxylate

Catalog No.: 
ACUBWZ759
CAS No.: 
921125-94-2
Molecular Formula: 
C14H14BrNO3
Molecular Weight: 
324.17
tert-Butyl 3-bromo-4-formyl-1H-indole-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$524.00InquiryInquiry
1g97%$857.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 3-bromo-4-formyl-1H-indole-1-carboxylate
IUPAC Nametert-butyl 3-bromo-4-formyl-1H-indole-1-carboxylate
Molecular FormulaC14H14BrNO3
Molecular Weight324.17
SMILESO=C(N1C=C(Br)C2=C1C=CC=C2C=O)OC(C)(C)C
InChI KeyPSTUNHJGXRGWHV-UHFFFAOYSA-N
Synonymtert-Butyl 3-bromo-4-formyl-1H-indole-1-carboxylate;1H-Indole-1-carboxylic acid, 3-bromo-4-formyl-, 1,1-dimethylethyl ester
CAS No.921125-94-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACUBWZ759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBCIR487 route compound structure diagram
    ACBCIR487143259-56-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBWZ759 route product structure diagram
    ACUBWZ759921125-94-2
Inquiry

2. ACUBWZ759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACUBWZ759 route product structure diagram
    ACUBWZ759921125-94-2
Inquiry

3. ACUBWZ759 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACUBWZ759 route product structure diagram
    ACUBWZ759921125-94-2
Inquiry

Comments (0)